SCHEMBL4164264

SCHEMBL4164264

COc1cc(F)ccc1CN1C(=O)c2ccccc2C1C(=O)Nc1c(C)cccc1C

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 6/20 0.56
ALDH1A1 P00352 3/20 0.55
LMNA P02545 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
F2 P00734 1/20 0.55
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
KCNH2 Q12809 1/20 0.52
NPSR1 Q6W5P4 2/20 0.51
RECQL P46063 1/20 0.51
POLB P06746 1/20 0.51
TSHR P16473 1/20 0.49
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
THRB P10828 1/20 0.47
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3934300 0.91 ALDH1A1 (0.54) KCNA5ALDH1A1LMNASMN1; SMN2F2
SCHEMBL4379312 0.90 KCNA5 (0.50) KCNA5ALDH1A1LMNASMN1; SMN2F2
SCHEMBL4377899 0.85 KCNA5 (0.54) KCNA5ALDH1A1LMNASMN1; SMN2F2
SCHEMBL3931555 0.84 ALDH1A1 (0.69) KCNA5ALDH1A1LMNASMN1; SMN2F2
SCHEMBL3937415 0.84 TP53 (0.51) KCNA5ALDH1A1LMNASMN1; SMN2F2
SCHEMBL4363829 0.84 ALDH1A1 (0.54) KCNA5ALDH1A1LMNASMN1; SMN2F2
SCHEMBL4008342 0.83 ALDH1A1 (0.56) KCNA5ALDH1A1LMNASMN1; SMN2F2
SCHEMBL3928404 0.83 ALDH1A1 (0.58) KCNA5ALDH1A1LMNASMN1; SMN2F2
SCHEMBL4159090 0.83 KCNA5 (0.53) KCNA5ALDH1A1LMNASMN1; SMN2F2
SCHEMBL3929089 0.83 THRB (0.66) KCNA5ALDH1A1LMNASMN1; SMN2F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090291983-A1 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents ASTRAZENECA AB (SE) 2009-11-26 US claimed
US-20090291983-A1 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents ASTRAZENECA AB (SE) 2009-11-26 US disclosed
EP-2044019-A1 3-OXOISOINDOLINE-1-CARBOXAMIDE DERIVATIVES AS ANALGESIC AGENTS Astra Zeneca AB (SE) 2009-04-08 EP disclosed
WO-2008008020-A1 3-OXOISOINDOLINE-1-CARBOXAMIDE DERIVATIVES AS ANALGESIC AGENTS ASTRAZENECA AB (SE) 2008-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291983-A1 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents OPRD1, OPRK1, OPRM1 KCNA5 536/4885ALDH1A1 429/4885LMNA 3171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.